Newsroom
Sorted by: Latest
-
Rimsys Announces AI-Native Market Access for Regulated Products
PITTSBURGH--(BUSINESS WIRE)--Rimsys announces Market Access, a new AI-native product that helps regulated product companies assess entering a market before committing resources....
-
Massachusetts Financial Services Company UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Massachusetts Financial Services Company (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
Balyasny Asset Management LP UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be...
-
NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will participate in the Morgan Stanley 24th Annual Global Healthcare Conference, Sept. 14–16, 2026, in New York....
-
Silver Bow Mining Intersects 994.2 g/t AgEq Over 4.0 m, including 1,586.1 g/t AgEq Over 2.3 m, from the Rainbow Block in Butte, Montana
BUTTE, Mont.--(BUSINESS WIRE)--Silver Bow Mining reports 994.2 g/t AgEq over 4.0 m at the Rainbow Block in Butte, Montana, including 1,586.1 g/t AgEq over 2.3 m....
-
Calluna Pharma Announces Participation in Upcoming Scientific and Investor Conferences
OSLO, Norway & BOSTON--(BUSINESS WIRE)--Calluna Pharma Announces Participation in Upcoming Conferences to highlight Phase 2 AURORA study of CAL101 in IPF ahead of planned Q1 2027 readout...
-
Samson Rock Capital LLP UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser SAMSON ROCK CAPITAL LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trus...
-
Polestar Sets the Date for Reporting the Second Quarter Select and Half-Year 2026 Results
GOTHENBURG, Sweden--(BUSINESS WIRE)--Polestar (Nasdaq: PSNY) expects to publish the second quarter select and half-year 2026 unaudited financial results on 3 September 2026, before market open. Management will host a conference call at 14:00 Central European Time (08:00 US Eastern Time) the same day, accessible via the Polestar Investor Relations website. To register and join the call, please use this link https://edge.media-server.com/mmc/p/czg84qrx/ or follow the instructions available under...
-
Great Hill Partners Announces Strategic Investment in Aurenity
BOSTON--(BUSINESS WIRE)--Great Hill Partners (“Great Hill”), a private equity firm that invests in high-growth, disruptive companies, today announced a strategic investment in Aurenity (the “Company”), a technology-enabled excess & surplus (“E&S”) managing general agent (“MGA”). Agman, Aurenity's founding investor, and the Company’s management team will retain a significant portion of their equity stakes in connection with the transaction. Financial terms were not disclosed. Great Hill'...
-
United Therapeutics Corporation Announces Participation at Upcoming Investor Conferences
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) announced today that company executives will provide overviews and updates during fireside chat sessions at four upcoming investor conferences. Martine Rothblatt, Chairperson and Chief Executive Officer, will present at the Wells Fargo 21st Annual Healthcare Conference in Boston on Tuesday, September 8, 2026, from 11:00 a.m. to 11:35 a.m., EST. Martine Rothblatt, Chairperson and Ch...